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Ave, Bronx, NY 10461. E-mail: marta.feldmesser@einstein.yu.edu.The recent outbreak of fungal disease associated with contami-
nated methylprednisolone acetate (MPA) injections forced the
practices of compounding pharmacies into the spotlight. The
causative organism in most of the cases was Exserohilum ros-
tratum, a black mold that is otherwise uncommonly seen as
a pathogen. This epidemic forced public health ofﬁcials to
confront an iatrogenic outbreak of unprecedented proportion
of a fungal disease for which there is no speciﬁc diagnostic test,
no animal model, little data to inform selection of optimal anti-
fungal therapy, and minimal information for determining dura-
tion of therapy.1 Central to the ability of the research community
to develop rational approaches to prevention, diagnosis, and
treatment is an understanding of disease pathogenesis.
In this issue of The American Journal of Pathology, Ritter
et al2 report on the pathology associated with this outbreak
while providing clinical and laboratory correlation. Their
ﬁndings support the presumed entry of fungi via cerebrospinal
ﬂuid (CSF) penetration from the injection site, with transport
via the CSF and basilar artery invasion. They also demon-
strate outstanding sensitivity of immunohistochemistry
(IHC) for fungal detection in tissue. This study signiﬁcantly
advances our understanding of E. rostratum pathogenesis.
The Outbreak
In September 2012, the Tennessee Department of Health re-
ported the ﬁrst cases of fungal meningitis to the Centers for
Disease Control and Prevention (CDC). These cases occurredCopyright ª 2013 American Society for Investigative Pathology.
Published by Elsevier Inc. All rights reserved.
http://dx.doi.org/10.1016/j.ajpath.2013.06.010in patients who had received epidural steroid injectionsmainly
for back pain, and the source of the outbreakwas rapidly traced
to three lots of preservative-free methylprednisolone acetate
produced at the New England Compounding Center (Fra-
mingham, MA). By the time the affected lots were recalled 8
days later, >13,000 people had been exposed during the
preceding four months.3 Subsequently, these lots were shown
to be contaminated with E. rostratum as well as with several
other bacteria and fungi.4 The high mortality associated with
thismultistate outbreaknecessitated very rapidmobilization of
the CDC with the organization of committees to deﬁne case
deﬁnitions, optimal approaches to therapy, and the establish-
ment of research priorities. The response on the part of public
health ofﬁcials was nothing short of heroic.
Early on in the epidemic, the predominant clinical syn-
dromes were meningitis and stroke. As the epidemic evolved,
epidural abscesses, paravertebral phlegma, sacroilitis, and
peripheral joint infections emerged as more common mani-
festations.1 Though the pace has slowed, additional cases
continue to be reported, with numbers standing at 749 cases
and 63 deaths in 20 states as of July 1, 2013 (CDC, http://
www.cdc.gov/hai/outbreaks/meningitis-map-large.html, last
accessed August 6, 2013). A report of a patient who has
Feldmesserrelapsed off therapy following presumed cure now has ap-
peared,5 highlighting the consequences of limited knowledge.
One positive consequence of the outbreak has been an
increased awareness by the medical community and the
general public of the existence of large scale compounding
centers that prepare medications for distribution to wide
areas without the degree of regulation placed on manufac-
turers. Fortunately, this attention has resulted in the intro-
duction of legislation in the US Senate that would give the
US Food and Drug Administration (FDA) broader regula-
tory powers (The New York Times, http://www.nytimes.com/
2013/05/23/us/politics/senate-committee-approves-bill-on-
compounding.html?_rZ0, last accessed June 20, 2013).6
Action cannot come soon enough, as evidenced by the
recent appearance of a new multistate outbreak of skin and
soft tissue infections associated with injection of MPA
produced at a compounding pharmacy in Tennessee, where
again, multiple bacterial and fungal species are being iso-
lated (CDC, http://www.cdc.gov/hai/outbreaks/TN-pharmacy/
index.html, last accessed June 20, 2013).
Black Molds and E. rostratum
Phaeohyphomycosis, deﬁned as “condition of fungi with dark
hyphae,” is a commonly used term that lumps together
diseases caused by >100 species of fungi in 60 genera
spanning several orders.7 This usage reﬂects the low
frequencywith which each of these organisms causes disease.
Though genomic sequencing for most of these organisms has
not been done, the potential evolutionary divergence is huge.
However, knowledge regarding pathogenesis of one is carried
to the others, albeit with a degree of necessity. The very
signiﬁcant morbidity and mortality from the current epidemic
provides the impetus to dissect the clinical and pathological
features of E. rostratum in great detail.
The dark color of the hyphal walls is due to melanin.
Although some blackmolds aremore geographically restricted,
Exserohilum spp. are broadly distributed. E. rostratum is iso-
lated from soil and marine environments.8 The organism is
a phytopathogen, particularly for grasses, and its use for
biocontrol of weeds has been studied.9 Three of the approxi-
mately 35 species of Exserohilum have been reported as causes
of human disease (E. rostratum, E. longirostratum, and
E. mcginnisii) though more recent multilocus sequence anal-
ysis suggests that all three may be conspeciﬁc.10
Pathogenesis of E. rostratum
Thecollection of samples from40patients in the report byRitter
et al2with analysis byonegroup represents a unique resource, as
earlier studies analyzed no more than two new cases each with
heavy reliance on repeated literature review. As Ritter et al2
observe, several features are consistent with what has been
seen previously,whereas others extend ourunderstanding of the
spectrum of disease, particularly since these cases are the ﬁrst662reports of E. rostratum meningitis. Based on prior cases, the
portals of entry include the respiratory tract, producing disease
of the sinuses and lungs, and traumatic inoculation, resulting in
skin or corneal disease, as well as osteomyelitis. Here, host
barriers obviously were breached by direct inoculation of the
organisms, which is consistent with prior routes. But, as dis-
cussed later in this section, some questions remain as to how the
epidural injections caused meningitis.
Ritter et al2 describe the spectrum of histopathology pre-
viously reported and note that their cases demonstrate the full
range of inﬂammatory responses. Interestingly, in tissue samples
from patients with only epidural or paraspinal infections at
the injection site, tissue more commonly had lymphohistio-
cytic inﬂammation, whereas in patients with meningitis, the
pathology of the injection site tissues was more necrosuppur-
ative, suggesting a more indolent process in the former group.
The overall fungal burden in tissue from these patients also was
lower. These patients also apparently presented later, though
statistical analysis for this comparison is not provided. Whether
these outcomes, which may represent qualitatively different
immune responses, reﬂect differences in the fungal inoculum,
host differences, or other factors remains unanswered.
As Ritter et al2 note, the pathogenesis of E. rostratum
meningitis is similar to that of other fungal pathogens in
terms of angioinvasion with resultant thrombosis and
infarction. The degree to which vascular invasion was seen
in this sample collection is striking. An interesting feature is
that fungi in vessels and dense connective tissue of injection
sites were not necessarily accompanied by inﬂammation,
though it is unclear whether or not these areas were rela-
tively avascular when present in connective tissue.
Ritter et al2 also note an apparent predilection for the base of
the brain despite inoculation in the lumbar or cervicothoracic
spine. The mold that most commonly causes CNS disease is
Aspergillus fumigatus. As they point out, this feature has been
seen in Aspergillus meningitis associated with epidural steroid
injections but not when CNS Aspergillus infection occurs
hematogenously. However, following either hematogenous
spread or extension from a contiguous focus, themost common
manifestation of CNS aspergillosis is abscess formation.
Meningitis, which occurs less commonly, mainly results from
involvementof adjacentbrain tissue.11CNSdisease due toother
agents of phaeohyphomycosis, which are thought to share the
same portals of entry as E. rostratum, mostly has been reported
as cerebritis or abscess.12 Thus, the absence of apparent basilar
predilection is less surprising in these instances. Involvement of
the basilar meninges with or without arterial invasion has been
described for other fungal pathogens, including Coccidioides
immitis and Cryptococcus neoformans,13,14 organisms for
which meningitis is a manifestation of disseminated disease,
though these pathogens typically produce a lymphocytic
meningitis. Similar tendency is seen in tuberculous meningitis,
as well as meningitis due to other bacterial pathogens. As sug-
gested in the present report, this distribution is not well under-
stoodbut likely results from the dynamics ofCSF circulation, as
studies with radionucleotide imaging after lumbar inoculationajp.amjpathol.org - The American Journal of Pathology
Commentarynot only show rapid appearance in the basal cisterns but accu-
mulation in this area beforemoving through the communicating
pathways.15 Thus, the basilar predominance may be less
reﬂective of properties of the organism than that of the physi-
ology of the host.
Very interesting and important are the twin observations
noting there was no evidence for either direct invasion from
the meninges into underlying parenchyma of the brain or
spinal cord, except at the injection site, and no dissemina-
tion to organs outside the CNS.2 Thus, though hyphae
invaded blood vessels extensively, and the authors present
EM evidence consistent with degradation of vessel walls,
they apparently did not penetrate the pia mater or establish
disease distally. The host-pathogen relationships that limited
deeper and metastatic spread remain unknown.
As Ritter et al2 discuss, an unanswered question is whether
meningitis resulted from direct inoculation via epidural punc-
ture, fungal invasion from the epidural/paraspinal space, or via
lymphatic ﬂow. The incidence of dural puncture as a compli-
cation of epidural injection is very difﬁcult to determine,
though a recent study reported rates ranging from 0.5% to
1.3%, depending on the location.16 Even when performed
under ﬂuoroscopic guidance, this complication may go
unrecognized, though the use of contrast can aid in detection,
and its occurrence may be underreported.17 In the analysis of
the clinical data from the Tennessee cases, two factors that
improved the ﬁtness of the model for assessment of risk factors
for diseasewere a translaminar approach and the use of contrast
material (adjusted odds ratios, 2.01 and 0.23, respectively).
However, they did not retain signiﬁcance in the multivariate
analysis.3 Should these factors remain signiﬁcant in the larger
data set, they could suggest a signiﬁcant role for dural puncture.
The variety of fungal morphological forms seen in tissue is
also interesting. Speciﬁcally, Ritter et al2 detected conidia
(spores) raising the possibility that in addition to vegetative
growth, the organism undergoes sporulation in tissue. Prior
descriptions of the organism in tissue refer either to hyphal
forms or to fungal elements. I have not seen conidia described
previously. However, the alternative possibility is that conidia
were present in the contaminated MPA and did not germinate.
Provision of more detail regarding the frequency of this
observation and the tissue location (injection site versus other)
might further clarify these possibilities. Whether or not sporu-
lation occurs in vivo, as happens with some fungal pathogens
but not others, has implications for the development of animal
models, aswell as for pathogenesis and treatment. Persistenceof
spores in tissue could result in maintenance of a potential focus
of infection that likelywould be refractory to antifungal therapy.
Nonculture-Based Diagnostics
Amajor clinical challenge formanagement of systemicmycoses
is the difﬁculty both in making a diagnosis of invasive fungal
disease and in identifying the speciﬁc causative organism. The
problem is made more urgent by the low sensitivity of fungal
culture and requirement for long periods for growth inThe American Journal of Pathology - ajp.amjpathol.orgcombination with the correlation between earlier diagnosis and
improved therapeutic outcome. The sensitivity of culture in the
present epidemic has been reported as 14%.18 IHC in the present
studywasoutstandingwith100%fungal detection in tissue from
the 40 cases. As noted by Ritter et al,2 the IHC strategy using
polyclonal antibodywith broad fungal cross-reactivity followed
by twomonoclonal antibodies to exclude more common fungal
pathogens does not allow speciﬁc attribution of disease to E.
rostratum. Therefore, an important caveat is that for 14 of the
cases,E. rostratum could not be directly conﬁrmed by culture or
PCR. The appearance of many phaeohyphomycosis agents in
tissue is similar. More speciﬁc reagents will likely be made in
response to this outbreak. The obvious disadvantages to reliance
on IHC, including the need for tissue as well as the time for
sample processing, make availability of molecular diagnostics
highly desirable.
Molecular methods, particularly PCR, have been explored
for fungal diagnostics for the past two decades. PCR-based
methods have potential to provide speciﬁc diagnoses within
very short time frames, but their development and imple-
mentation into clinical diagnostics have been hampered by
difﬁculties in identifying fungal DNA in complex clinical
samples as well as by environmental contamination.19 CDC
scientists developed a PCR protocol for investigation of this
outbreak, which was less sensitive than IHC for detecting
fungi in tissue. The strategy used for PCR development used
broad-spectrum fungal primers that amplify a segment of
ribosomal DNA genes that includes the internal transcribed
spacer 2 region, a second PCR using primers speciﬁc for
E. rostratum, and the use of ampliﬁed products for species
conﬁrmation by sequence analysis.18 This approach proved
critically important, as multiple fungi were isolated from
clinical samples, as well as from the contaminated lots of
MPA, and the causative organism in the majority of cases
previously had been found only rarely in human disease.
Diagnostically, PCR is most useful outside the context of an
outbreak investigation when organisms are detectable in bio-
logical ﬂuids such as blood or, in this case, CSF. Though the
reported limit of detection for this PCR is approximately 1 pg/
mLofDNA (or an estimated 23 genomes/mLofE. rostratum),
the assay was positive in CSF samples from only 24% of case
patients with meningitis tested at the CDC. Ritter et al2 report
positivity on one or more tissues from 50% of patients from
whom samples were available, which is also quite low. The
authors attribute the low sensitivity to difﬁculties in DNA
extraction frommelanized fungi. In a recently published CDC
preliminary laboratory report from this epidemic, Lockhart
et al4 proposed that one likely reason was improper sample
handling, particularly early in the outbreak. This suggestion
would be supported by the somewhat better apparent perfor-
mance of the assay in the present study on formalin-ﬁxed,
parafﬁn-embedded samples compared to those from fresh
tissue, a result that would not necessarily be predicted, though
both types of specimens were available only for a very small
number of samples. In response to the outbreak, investigators
at the Public Health Research Institute Center (Newark, NJ)663
Feldmesserhave already developed a molecular beacon real-time PCR
assay speciﬁc for E. rostratum.20 Though the sensitivity for
clinical isolates is reportedly approximately 100 fg of fungal
DNA, even in the presence of human DNA, the performance
characteristics of this assay in clinical samples have not yet
been reported. Accurate determination of the performance of
either assay will require further study.
Unanswered Questions
The epidemic remains ongoing and clinical follow up is not
complete for all of the cases. This information will be
important for assessment of optimal therapy and deﬁnition of
the role of surgical approaches to management. Little is
known about the biology of E. rostratum itself. However,
regarding the intersection of clinical and epidemiological
features with pathology and pathogenesis, several additional
intriguing questions remain. First, as raised by Ritter et al,2
the organisms were inoculated in steroids, which are immu-
nosuppressive drugs. In addition, as has been discussed
recently in the context of this outbreak, many fungi have
sterol receptors and exposure can increase their growth.21
There have been rare case reports of dermal E. rostratum
disease believed to be related to topical or intramuscular
steroids.22 Did the presence of steroids participate in disease
pathogenesis in these patients, and if so, how?
A second set of questions relates to the case attack rate: of
more than 13,000 exposed, 745 have developed disease.
Some factors associated with the injected solutions, such as
the speciﬁc lot as well as the interval between production
and administration, have been identiﬁed as risk factors and
likely relate to fungal burden.3 Did additional clinical
factors, such as the technique used for corticosteroid injec-
tion or the use of contrast during ﬂuoroscopy, play a role?
Did underlying morbidities predispose patients to disease?
Did additional host factors, such as genetic polymorphisms
in immune molecules, enhance susceptibility?
In the meantime, the scientiﬁc community is discussing
and undertaking the broad ranging types of study needed to
equip the ﬁeld with tools to develop diagnostic and treat-
ment strategies for invasive disease due to E. rostratum.21
Perhaps the disease has earned its own name e invasive
exserohilosis?
References
1. Pappas PG, Kontoyiannis DP, Perfect JR, Chiller TM: Real-time
treatment guidelines: considerations during the Exserohilum rostratum
outbreak in the United States. Antimicrob Agents Chemother 2013, 57:
1573e1576
2. Ritter JM, Muehlenbachs A, Blau DM, Paddock CD, Shieh WJ,
Drew CP, Batten BC, Bartlett NH, Metcalfe MG, Pham CD,
Lockhart SR, Patel M, Liu L, Jones TL, Greer PW, Montague JL,
White E, Rollin DC, Seales C, Steward D, Deming MV, Brandt ME,
Zaki SR; Exserohilum Infections Working Group: Exserohilum
infections associated with contaminated steroid injections: a clinico-
pathologic review of 40 cases. Am J Pathol 2013, 183:881e8926643. Kainer MA, Reagan DR, Nguyen DB, Wiese AD, Wise ME, Ward J,
Park BJ, Kanago ML, Baumblatt J, Schaefer MK, Berger BE,
Marder EP, Min JY, Dunn JR, Smith RM, Dreyzehner J, Jones TF;
Tennessee Fungal Meningitis Investigation Team: Fungal infections
associated with contaminated methylprednisolone in Tennessee. N
Engl J Med 2012, 367:2194e2203
4. Lockhart SR, Pham CD, Gade L, Iqbal N, Scheel CM, Cleveland AA,
Whitney AM, Noble-Wang J, Chiller TM, Park BJ, Litvintseva AP,
Brandt ME: Preliminary laboratory report of fungal infections associ-
ated with contaminated methyprednisolone injections. J Clin Microbiol
2013, 51:2654e2661
5. Smith RM, Tipple M, Chaudry MN, Schaefer MK, Park BJ: Relapse of
fungal meningitis associated with contaminated methylprednisolone.
N Engl J Med 2013, 368:2535e2536
6. Drazen JM, Curfman GD, Baden LR, Morrissey S: Compounding
errors. N Engl J Med 2012, 367:2436e2437
7. Revankar SG, Sutton DA: Melanized fungi in human disease. Clin
Microbiol Rev 2010, 23:884e928
8. Adler A, Yaniv I, Samra Z, Yacobovich J, Fisher S, Avrahami G,
Levy I: Exserohilum: an emerging human pathogen. Eur J Clin
Microbiol Infect Dis 2006, 25:247e253
9. Chandramohan S, Charudattan R: Control of seven grasses with
a mixture of three fungal pathogens with restricted host ranges. Biol
Control 2001, 22:246e255
10. da Cunha KC, Sutton DA, Gené J, Capilla J, Cano J, Guarro J:
Molecular identiﬁcation and in vitro response to antifungal drugs of
clinical isolates of Exserohilum. Antimicrob Agents Chemother 2012,
56:4951e4954
11. Schwartz S, Ruhnke M: Aspergillus sinusitis and cerebral aspergillosis.
Aspergillus fumigatus and aspergillosis, vol. 1, ed 1, ch 24. Edited by
Latgé J-P, SteinbachWJ.WashingtonDC, ASMPress, 2009, pp 301e317
12. Kantarcioglu AS, de Hoog GS: Infections of the central nervous
system by melanized fungi: a review of cases presented between 1999
and 2004. Mycoses 2004, 47:4e13
13. Williams PL, Johnson R, Pappagianis D, Einstein H, Slager U,
Koster FT, Eron JJ, Morrison J, Aguet J, River ME: Vasculitic and
encephalitic complications associated with Coccidioides immitis
infection of the central nervous system in humans: report of 10 cases
and review. Clin Infect Dis 1992, 14:673e682
14. Mangham D, Gerding DN, Peterson LR, Sarosi GA: Fungal meningitis
manifesting as hydrocephalus. Arch Intern Med 1983, 143:728e731
15. James AE Jr., DeLand FH, Hodges FJ 3rd, Wagner HN Jr.: Cerebro-
spinal ﬂuid (CSF) scanning: cisternography. Am J Roentgenol Radium
Ther Nucl Med 1970, 110:74e87
16. Manchikanti L, Malla Y, Wargo BW, Cash KA, Pampati V, Fellows B:
A prospective evaluation of complications of 10,000 ﬂuoroscopically
directed epidural injections. Pain Physician 2012, 15:131e140
17. Goodman BS, Bayazitoglu M, Mallempati S, Noble BR, Geffen JF:
Dural puncture and subdural injection: a complication of lumbar
transforaminal epidural injections. Pain Physician 2007, 10:697e705
18. Gade L, Scheel CM, Pham CD, Lindsley MD, Iqbal N, Cleveland AA,
Whitney AM, Lockhart SR, Brandt ME, Litvintseva AP: Detection of
fungal DNA in human body ﬂuids and tissues during a multistate outbreak
of fungalmeningitis and other infections. EukaryotCell 2013, 12:677e683
19. Kourkoumpetis TK, Fuchs BB, Coleman JJ, Desalermos A,
Mylonakis E: Polymerase chain reaction-based assays for the diagnosis
of invasive fungal infections. Clin Infect Dis 2012, 54:1322e1331
20. Zhao Y, Petraitiene R, Walsh TJ, Perlin DS: A real-time PCR assay for
rapid detection and quantiﬁcation of Exserohilum rostratum, a causative
pathogen of fungal meningitis associated with injection of contaminated
methylprednisolone. J Clin Microbiol 2013, 51:1034e1036
21. Kontoyiannis DP, Perlin DS, Roilides E, Walsh TJ: What can we learn
and what do we need to know amidst the iatrogenic outbreak of
Exserohilum rostratum meningitis? Clin Infect Dis 2013, [Epub] http://
dx.doi.org/10.1093/cid/cit283
22. Hsu MM, Lee JY: Cutaneous and subcutaneous phaeohyphomycosis
caused byExserohilum rostratum. JAmAcadDermatol 1993, 28:340e344ajp.amjpathol.org - The American Journal of Pathology
